Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| AGHDA: Avaluació de la Deficiència d'Hormona del Creixement en Adults× | ThyPRO: Escala d'Hasil Reportat pels Pacients Relacionat amb la Tiroide× | |
|---|---|---|
| Camp | Endocrinologia | Endocrinologia |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 2000 | 2009 |
| Autor original≠ | Anthony Hunt, Garry Werther, Peter Wrightson | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| Tipus | Patient self-report questionnaire | Patient self-report questionnaire |
| Font seminal≠ | Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346. link ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| Àlies≠ | AGHDA-25 | ThyPRO-85, ThyPRO-39 |
| Relacionats | 3 | 3 |
| Resum≠ | The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateConjunt de dades ↗ |
|
|